A pilot study of vitamin E versus vitamin E and pioglitazone for the treatment of nonalcoholic steatohepatitis
โ Scribed by Sanyal, Arun J.; Mofrad, Pouneh S.; Contos, Melissa J.; Sargeant, Carol; Luketic, Velimir A.; Sterling, Richard K.; Stravitz, R. Todd; Shiffman, Mitchell L.; Clore, John; Mills, Alan S.
- Book ID
- 123021616
- Publisher
- Elsevier Science
- Year
- 2004
- Tongue
- English
- Weight
- 183 KB
- Volume
- 2
- Category
- Article
- ISSN
- 1542-3565
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Nonalcoholic steatohepatitis (NASH) is a common chronic liver disease for which there is no known effective therapy. A proportion of patients with NASH progress to advanced fibrosis and cirrhosis. NASH is considered one of the clinical features of the metabolic syndrome in which insulin resistance p
Shorter duration and lower dose of peginterferon alfa-2a therapy results in inferior HBeAg seroconversion rates compared with the duration and dose of 48 weeks and 180 lg: NEPTUNE study.